- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02767102
Bioavailability and Bioactivity of Red Wine Melatonin in Humans (Wine-MLT)
Serum and Salivary Melatonin Levels and Antioxidant Power of Melatonin-rich Red Wine
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Melatonin (MLT) is a bioactive compound in red wine. No information is currently available on serum and salivary concentrations of MLT after drinking a glass of red wine, containing this indoleamine. Hence, in this study, the investigators will investigate the levels of MLT, in serum and saliva, soon after the intake of the MLT-rich red wine, and, correspondingly, they will verify the antioxidant power of the same biological fluids.
This will be a randomized, crossover, double-blind, placebo-controlled study with two treatment arms. Twelve healthy volunteers will be recruited to receive both 125 mL of red wine rich in MLT (10 ng mL-1) and without MLT (placebo), via a randomized, cross-over, and double-blind design.
Serum and salivary MLT will be measured by liquid chromatography coupled to mass spectrometry (LC-MS) and enzyme-linked immunosorbent (ELISA), respectively. The ferric ion reducing antioxidant power (FRAP) will be also analyzed.
For serum analyses, samples will be collected at 0, 30, 60 and 90 min. For saliva analyses, samples will be collected at 0, 45 and 120 min.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Milano, Italy, 20142
- University of Milan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- to be healthy
- to have normal weight (BMI 18.5-25.0)
- to voluntarily accept to participate to the study.
Exclusion Criteria:
- pregnancy and lactation for women;
- supplementation with MLT and/or any other dietary supplement (vitamins, antioxidants, botanicals, phytochemicals)
- systemic and chronic-degenerative diseases
- abnormal hematological parameters
- heavy smoking and alcohol drinking
- high-intensity physical activity
- under pharmacological treatment
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Red wine with Melatonin
Rosso di Marco is a wine without MLT (previous screening).
This wine will be enriched with 10 ng mL-1 MLT (MLT+) and used as experimental wine.
|
Twelve healthy volunteers will be recruited to receive both 125 mL of red wine rich in MLT (10 ng mL-1)
|
Placebo Comparator: Red wine without Melatonin
Rosso di Marco is a wine without MLT (previous screening).
This wine will be used as placebo treatment (PLC).
|
Twelve healthy volunteers will be recruited to receive both 125 mL of red wine without MLT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum and salivary melatonin after red wine intake (with or without MLT)
Time Frame: Time-course of the serum melatonin levels in healthy volunteer from 0 min to 90 min after administration of red wine. Time-course of the salivary melatonin levels in healthy volunteer from 0 min to 120 min after administration of red wine.
|
LC-MS analyses for serum and ELISA analyses for saliva
|
Time-course of the serum melatonin levels in healthy volunteer from 0 min to 90 min after administration of red wine. Time-course of the salivary melatonin levels in healthy volunteer from 0 min to 120 min after administration of red wine.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Antioxidant power of saliva and serum after red wine intake (with or without MLT)
Time Frame: Time-course of the serum antioxidant power in healthy volunteer from 0 min to 90 min after administration of red wine. Time-course of the salivary antioxidant power in healthy volunteer from 0 min to 120 min after administration of red wine.
|
FRAP analyses
|
Time-course of the serum antioxidant power in healthy volunteer from 0 min to 90 min after administration of red wine. Time-course of the salivary antioxidant power in healthy volunteer from 0 min to 120 min after administration of red wine.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adverse effects
Time Frame: Acute side effects during the trial recorded at each experimental day each experimental day, up to 1 day after
|
Questionnaire
|
Acute side effects during the trial recorded at each experimental day each experimental day, up to 1 day after
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Red Wine Melatonin
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bioavailability
-
Initiator PharmaNot yet recruiting
-
Fundació EurecatURIACH, S.L.Completed
-
WockhardtCompletedBioavailabilityUnited States
-
Midwest Center for Metabolic and Cardiovascular...NaturmegaCompleted
-
University of AarhusCompletedBioavailabilityDenmark
-
Cessatech A/SSmerud Medical Research International AS; Dantrials ApsCompleted
-
University of Maryland, BaltimoreFood and Drug Administration (FDA)Completed
-
Rousselot BVBABioTeSys GmbHCompleted
-
University of UtahCompleted
-
KGK Science Inc.ChromaDex, Inc.Completed
Clinical Trials on Red wine with melatonin
-
University of California, DavisCompletedVascular Function; Platelet AggregationUnited States
-
University of TurkuTampere UniversityCompleted
-
Cedars-Sinai Medical CenterCompletedHealthyUnited States
-
Universidade do PortoCenter for Health Technology and Services Research; REQUIMTE/LAQV, Departamento... and other collaboratorsCompleted
-
Amsterdam UMC, location VUmcCompleted
-
Bayside HealthTerminatedType 2 Diabetes | Heart DiseaseAustralia
-
University Hospital, LinkoepingCompletedHealthy Subjects
-
European Research Advisory BoardCompleted
-
University of the Highlands and IslandsCompletedEndothelial DysfunctionUnited Kingdom
-
Parc de Salut MarCompleted